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Purpose: Radiofrequency catheter ablation of the cavotricuspid isthmus (CTI) is effective in the
treatment of typical atrial ﬂutter (AFL) and atrial ﬁbrillation (AF). AF and AFL often coexist.
However, AF often occurs following successful ablation of CTI. The aim of this study was to
investigate the predictors of concomitant AF following successful ablation of AFL.
Methods: We enrolled 122 patients [59.1± 11.3 years, male 100 (82.0%)] with typical AFL, who
received successful ablation of the CTI. They were followed up at outpatient clinic (24.6± 25.7
months). Twelve-lead electrocardiogram and Holter monitoring were used to conﬁrm the diag-
nosis of recurrent AFL or AF. We assessed prior history of AF, structural heart disease, left
ventricular ejection fraction, left atrial diameter (LAD), left atrial volume index (LAVI), and
AFL cycle length.
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Results: Among the 122 ablated patients, 15 (12.3%) had recurrent AFL and 33 (27.0%) had recur-
rent AF. In univariate logistic analysis, LAD and LAVI could signiﬁcantly predict the recurrence
of AF after AFL ablation. However, multivariate logistic regression analysis found that the inde-
pendent predictor of recurrent AF was LAVI. An LAVI of 42.6mL may allow for the differentiation








































unpaired Student’s t-test or analysis of variance. Categori-
cal data and proportions were analyzed using the Chi-square
test. Univariate and multivariate analysis were performedConclusions: LAVI might be a
© 2010 Published by Elsevier
Introduction
Atrial ﬁbrillation (AF) and atrial ﬂutter (AFL) are the most
common sustained atrial arrhythmias and often coexist.
Both arrhythmias have similar pathophysiological features
including electrical remodeling [1] and shortened action
potential duration [2] and similar clinical predictors such
as hypertension, heart failure, and pulmonary disease
[3—5]. In addition, many authors reported that 30—73%
patients developed AF during long-term follow up period
after successful radiofrequency catheter ablation of the
cavotricuspid isthmus (CTI) in patients with typical AFL
[6—8].
It might be important to predict the occurrence of AF
after ablation of AFL. Although several factors have been
reported as predictors of an occurrence of AF during long-
term follow up, few data are available on the predictive
parameters of AF. Therefore, the purpose of our study was
to investigate the predictors of concomitant AF following
successful ablation of AFL.
Subjects and methods
Patient population
From January 1998 to April 2007, 122 consecutive symp-
tomatic patients with typical AFL were retrospectively
included in this study. CTI-dependence of AFL was diag-
nosed by the presence of a characteristic pattern on the
surface electrocardiogram (ECG) (negative sawtooth waves
in lead II, III, and aVF and usually positive waves in lead
V1) and/or entrainment mapping during electrophysiologi-
cal (EP) study [9]. However, we excluded the patients with
irregular interval between atrial and ventricular waves to
rule out an organizing AF in our study.
Electrophysiologic testing and ablation procedure
Each patient underwent EP study and catheter ablation
in the fasting, non-sedative state after written informed
consent was obtained. All anti-arrhythmic drugs except
amiodarone were discontinued for at least ﬁve half-lives
before the study. The patients stopped their antithrom-
botic treatment 48 h before the procedure in order to have
an international normalized ratio <1.7. CTI ablation was
performed by creating a linear lesion from the tricuspid
annulus to the inferior vena cava using 4- and/or 8-mm tip
electrode catheters. Radiofrequency (RF) ablation was con-
tinued until either no electrogram or consistent reduction of
the electrograms amplitude of at least 90% was documented
across the isthmus. The end-point of the procedure was the
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isting at least 30min after the last RF energy application
10,11].
chocardiographic analysis
ransthoracic Doppler echocardiography was performed
ithin 24 h of the RF ablation procedure. All echocar-
iographic parameters were measured according to the
ecommendations of the American Society of Echocardiog-
aphy [12]; left ventricular ejection fraction was calculated
y planimetry in the apical two- and four-chamber views
ith the modiﬁed Simpson rule. Measurement of left atrial
LA) diameter from M-mode was guided by parasternal
hort-axis image at level of aortic valve. LA volumes are
alculated using either an ellipsoid model or Simpson’s
ule. Left atrial long axis and short axis were obtained by
lanimetry of the atrial inner borders with maximized atrial
hamber size at end-systole in the four- and two-chamber
iews.
ollow-up
ral anticoagulation was pursued for at least 1 month.
hereafter, the need for anticoagulation was assessed
ccording to the presence of risk factors for thromboem-
olism [13]. Whenever possible, anti-arrhythmic agents
ere stopped after the procedure in patients with lone AFL.
nti-arrhythmic agents were continued in patients with a
istory of prior AF. Patients attended the outpatient clinic
t 1 month, and at 3, 6, and 12 months for a 12-lead ECG
r a 24-h Holter recording. Also, a 12-lead ECG and a 24-h
olter recording were evaluated when patients felt symp-
oms suggestive of tachycardia. The development of AF or
he recurrence of AFL was deﬁned by documentation on a
2-lead ECG or a 24-h Holter monitoring.
tatistical analysis
he SPSS 15.0 (SPSS Inc., Chicago, IL, USA) statistical
oftware package was used for all calculations. Data are
resented as means± standard deviation for continuous
ariables and as percentages for categorical data. The
ontinuous variables among groups were analyzed by thesing logistic regression analyses to determine the indepen-
ent predictive factors of AF after typical AFL ablation. The
ctuarial probability of freedom from AF after AFL ablation
as calculated with the Kaplan—Meier method and the dif-
erences between the curves were tested for signiﬁcance by
350
Table 1 Demographic characteristics.
No. of Pt. 122
Age (years) 59.1± 11.3
Male (%) 100 (82.0%)
Diabetes (%) 13 (10.7%)
Hypertension (%) 26 (21.3%)
Ischemic heart disease (%) 9 (7.4%)
Congestive heart failure (%) 16 (13.1%)
Intracardiac Op. d/t SHD 15 (12.3%)
Prior AF (%) 48 (39.3%)
Prior History of AAA (%) 49 (40.2%)
Duration of AFL (months) 11.3± 6.2
LV ejection fraction (%) 55.6± 12.5
LA diameter (cm) 4.40± 0.66
LA volume index (mL/m2) 43.2± 16.7
Mitral regurgitation (%) 19 (13.7%)


















































DiscussionOp.: operation; SHD: structural heart disease; AF: atrial ﬁbril-
lation; AAA: anti-arrhythmic agent; AFL: atrial ﬂutter; LV: left
ventricle; LA: left atrium.




able 1 presents the demographic characteristics of the
tudy population. There were 100 men and 22 women. Mean
ge was 59.1± 11.3 years. All patients were followed for
4.6 months after ablation. Twelve percent of the patients
ad corrective cardiac surgery for congenital heart disease
uch as atrial septal defect, ventricular septal defect, and
atent ductus arteriosus. Forty percent of the patients had a
istory of prior AF. Transthoracic echocardiographic param-
ters such as left ventricular ejection fraction, LA diameter,
nd LA volume index were normal. Fourteen percent of





Table 2 Results of CTI ablation in overall population.
Sinus
No. of Pt. 74 (60.7%)
Age (years) 58.6± 12.3
Male (%) 69 (83.1%)
Prior AF (%) 29 (39.2%)
Intracardiac operation 10 (13.5%)
History of AAA (%) 30 (36.1%)
LV ejection fraction (%) 54.7± 12.9
LA diameter (cm) 4.22± 0.64
LA volume index (mL/m2) 38.9± 12.2
Mitral regurgitation (%) 13 (15.9%)
Flutter cycle length (ms) 236.8± 38.8
Time to ﬁrst AF or AFL (months)
CTI: cavo-tricuspid isthmus; AFL: atrial ﬂutter; AF: atrial ﬁbrillation; AY.-S. Lee et al.
ollow-up results after CTI ablation
he mean follow-up duration was about 2 years. During
ollow-up, 15 patients (12.3%) and 33 (27.0%) showed recur-
ences of AFL and occurrence of AF, respectively. In addition,
4 (60.7%) remained in sinus rhythm. Those with occurrence
f AF included 8 with early occurrence (within 3 months
fter ablation) and 25 with late occurrence (greater than 3
onths). Among the 14 patients with prior AF, there were
with early occurrence and 9 with late occurrence. Among
roups, there was no difference in age, proportion of prior
F, presence of intracardiac operation, medication of anti-
rrhythmic agent, left ventricular ejection fraction, and
ncidence of mitral regurgitation (Table 2). However, LA
iameter and LA volume index in patients with occurrence
f AF was signiﬁcantly larger in patients with sinus rhythm
r recurrence of AFL (p < 0.001).
redictors for occurrence of atrial ﬁbrillation
nivariate analysis showed that patients who experienced
ccurrence of AF were more likely to have a larger LA diam-
ter (>4.5 cm) and LA volume index (>42.6mL/m2) than
atients who sustained sinus rhythm (Table 3). However,
ultivariate analysis showed that only LA volume index
>42.6mL/m2) were associated signiﬁcantly with time to
ccurrence of AF after CTI ablation in AFL (hazard ratio
.788, 95% conﬁdence interval: 1.331—10.779; p = 0.013).
n a subgroup analysis of patients with or without prior
F history, larger LA diameter and LA volume index were
igniﬁcant predictors in univariate analysis. In multivariate
nalysis, LA volume index might predict the occurrence of
F, even though statistically not signiﬁcant (Table 4). Fig. 1
emonstrates the Kaplan—Meier analysis of survival free of
F according to LA volume index (deﬁned as LA volume index
42.6mL/m2).his study ﬁrstly demonstrated that LA volume index might
e a useful predictor of AF occurrence after a CTI abla-
ion of typical AFL. In our study, during a mean follow-up
AFL AF p
15 (12.3%) 33 (27.0%)
62.5± 8.5 59.3± 9.3 NS
12 (92.3%) 19 (73.1%) NS
5 (38.5%) 14 (42.4%) NS
2 (13.3%) 3 (9.1%) NS
8 (61.5%) 11 (42.3%) NS
57.0± 14.8 57.3± 9.9 NS
4.46± 0.72 4.77± 0.53 <0.001
41.0± 21.9 53.6± 18.7 <0.001
1 (7.7%) 5 (19.2%) NS
246.5± 26.4 225.7± 38.6 NS
15.0± 22. 20.0± 21.5 NS
AA: anti-arrhythmic agent; LV: left ventricle; LA: left atrium.
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Table 3 Univariate and multivariate regression analysis for predictors of AF occurrence after ablation of AFL.
Univariate analysis Multivariate analysis
Hazard ratio 95% CI p Hazard ratio 95% CI p
Age 1.029 0.991, 1.069 0.138 1.027 0.980, 1.077 0.265
Prior history of AF 1.143 0.497, 2.631 0.753
Mitral regurgitation 1.604 0.558, 4.605 0.380 1.026 0.575, 6.555 0.286
LV ejection fraction 0.999 0.965, 1.033 0.938
Medication of AAA 1.633 0.707, 3.774 0.251 1.482 0.550, 3.992 0.437
LAD > 4.5 cm 3.670 1.524, 8.838 0.004 2.365 0.845, 6.616 0.101
LAM> 42.6mL/m2 5.146 1.984, 13348 0.001 3.564 1.265, 10.039 0.016
CI: conﬁdence interval; AF: atrial ﬁbrillation; AFL: atrial ﬂutter; AAA: anti-arrhythmic agent; LV: left ventricle; LAD: left atrial diameter;
LAYI: left atrial volume index.
Table 4 Univariate and multivariate regression analysis for predictors of AF occurrence after ablation of AFL.
Without prior AF (n = 64) With prior AF (n = 43)
Univariate Multivariate Univariate Multivariate
Hazard n ratio p Hazard n ratio p Hazard n ratio p Hazard n ratio p
Age 1.052 0.051 1.055 0.097 0.986 0.686
Mitral regurgitation 2.286 0.263 1.045 0.955
LV ejection fraction 1.013 0.572 0.974 0.369
Medication of AAA 2.215 0.159 1.765 0.418
LAD > 4.5 cm 4.513 0.013 2.001 0.351 2.815 0.125 2.291 0.267
LAVI > 42.6mL/m2 5.370 0.009 3.584 0.087 5.000 0.038 4.394 0.061
CI: conﬁdence interval; AF: atrial ﬁbrillation; AFL: atrial ﬂutter; AAA: anti-arrhythmic agent; LV: left ventricle; LAD: left atrial diameter;
LAVI: left atrial volume index.
Fig. 1 Kaplan—Meier analysis of freedom from atrial ﬁbrillation (AF) after cavo-tricuspid isthmus (CTI) ablation of atrial ﬂutter








































































f 24.6± 25.7 months, AFL recurred in 12.3% of patients
n = 15) and AF occurred in 27.0% of patients (n = 33) after
CTI ablation of typical AFL.
AF and AFL have been known to share common patho-
hysiological features including electrical remodeling [1]
nd shortened action potential duration [2]. Also, Ohmura et
l. [14] demonstrated that a very short cycle length of AFL
ircuit could result in ﬁbrillatory conduction. Conversely,
oithinger et al. [15] suggested that initiation and perpetu-
tion of typical AFL depend on the existence of a functional
ine of block, which is developed during transitional rhythm
receding AF [16].
In clinical practice, this close interplay between AFL and
F also translates into a high incidence of AF following CTI
blation of typical AFL, ranging from 17 to 58% after a follow-
p of 6—36 months [17—24]. In our study, AF occurred in
7.0% of patients during a mean follow-up of 24.6± 25.7
onths, which is a similar result compared to previous stud-
es. This various occurrence rate of AF was explained by
uration of follow-up and asymptomatic AF.
Several authors reported a variety of predictors for occur-
ence of AF after AFL ablation. Hsieh et al. [6] demonstrated
hat prior history of AF and inducible AF might be predictors
or the early occurrence of AF, and prior history of AF was
he only predictor for late occurrence of AF. In our study,
rior history of AF was not associated with occurrence of AF.
his may be due to the use of anti-arrhythmic agents during
ollow-up. Da Costa et al. [20] showed that mitral regurgi-
ation was the only independent predictor of AF in patients
ithout a prior history of AF. In patients with a prior history
f AF, left ventricular ejection fraction was the only inde-
endent predictor of AF following the ablation. In our study,
A volume index (>42.6mL/m2) might predict the occur-
ence of AF regardless of prior AF history. This controversy
ould be explained by the fact that most patients had nor-
al left ventricular function and a small number of patients
ad mitral regurgitation. Ellis et al. [25] also noted that LA
ize was a predictor of AF recurrence after AFL ablation. In
ur study, dilated LA dimension could predict occurrence of
F in univariate analysis. In addition, enlarged LA volume
ndex could be the only predictor for occurrence of AF in
ultivariate analysis.
Our study, as well as other published studies, has pointed
ut a possibility of AF after AFL ablation. Therefore, sev-
ral parameters including prior history and inducibility of
F, enlarged LA volume, and left ventricular dysfunction
hould be included in deciding on treatment for patients
aking anti-arrhythmic and antithrombotic agents after AFL
blation.
The limitations of this study include the following. First,
ur study is limited by its retrospective analysis. Second,
e may also have underestimated the patients with asymp-
omatic episodes of AF, or due to the anti-arrhythmic drugs
reated in cases after the ablation, which may prevent AF
ecurrences. However, Roy et al. [26] reported that amio-
arone and propafenone could prevent recurrence of AF in
5% and 37% for 2 years, respectively. Also, in the AFFIRM
tudy [27], AF recurrence in the rhythm control group was
bserved at 26.7% at 3 years even though so many underwent
ardioversion. In our study, only 25% of the patients who
ad prior AF history and were treated with anti-arrhythmic
edication were found to AF occurrence, which is notY.-S. Lee et al.
ully explained only by effect of anti-arrhythmic medica-
ion. Third, because the study included a small number of
atients, large-scale and long-term follow-up studies are
equired to conﬁrm this ﬁnding.
Nevertheless, in conclusion, the present results suggest
hat LA volume index might be a useful predictor for occur-
ence of AF after ablation of typical AFL.
cknowledgment
his work was supported by the grant No. RTI04-01-01 from
he Regional Technology Innovation Program of the Ministry
f Commerce, Industry and Energy (MOCIE).
eferences
[1] Franz MR, Karasik PL, Li C, Moubarak J, Chavez M. Electrical
remodeling of the human atrium: similar effects in patients
with chronic atrial ﬁbrillation and atrial ﬂutter. J Am Coll Car-
diol 1997;30:1785—92.
[2] Wu TJ, Kim YH, Yashima M, Athill CA, Ting CT, Karagueuzian HS,
Chen PS. Progressive action potential duration shortening and
the conversion from atrial ﬂutter to atrial ﬁbrillation in the iso-
lated canine right atrium. J Am Coll Cardiol 2001;38:1757—65.
[3] Granada J, Uribe W, Chyou PH, Maassen K, Vierkant R, Smith
PN, Hayes J, Eaker E, Vidaillet H. Incidence and predictors
of atrial ﬂutter in the general population. J Am Coll Cardiol
2000;36:2242—6.
[4] Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic
predictors of nonrheumatic atrial ﬁbrillation. The Framingham
Heart Study. Circulation 1994;89:724—30.
[5] Hsieh MH, Tai CT, Tsai CF, Yu WC, Lin WS, Huang JL, Ding YA,
Chang MS, Chen SA. Mechanism of spontaneous transition from
typical atrial ﬂutter to atrial ﬁbrillation: role of ectopic atrial
ﬁbrillation foci. Pacing Clin Electrophysiol 2001;24:46—52.
[6] Hsieh MH, Tai CT, Chiang CE, Tsai CF, Yu WC, Chen YJ, Ding YA,
Chen SA. Recurrent atrial ﬂutter and atrial ﬁbrillation after
catheter ablation of the cavotricuspid isthmus: a very long-
term follow-up of 333 patients. J Interv Card Electrophysiol
2002;7:225—31.
[7] Halligan SC, Gersh BJ, Brown Jr RD, Rosales AG, Munger TM,
Shen WK, Hammill SC, Friedman PA. The natural history of lone
atrial ﬂutter. Ann Intern Med 2004;140:265—8.
[8] Moubarak G, Pavin D, Laviolle B, Solnon A, Kervio G, Daubert
JC, Mabo P. Incidence of atrial ﬁbrillation during very long-term
follow-up after radiofrequency ablation of typical atrial ﬂutter.
Arch Cardiovasc Dis 2009;102:525—32.
[9] Henthorn RW, Okumara K, Olshansky B, Plumb VJ, Hess
PG, Waldo AL. A fourth criterion for transient entrainment:
the electrogram equivalent of progressive fusion. Circulation
1988;77:1003—12.
10] Poty H, Saoudi N, Nair M, Anselme F, Letac B. Radiofrequency
catheter ablation of atrial ﬂutter. Further insights into the var-
ious types of isthmus block: application to ablation during sinus
rhythm. Circulation 1996;94:3204—13.
11] Rhee KS, Kwon KS, Lee SH, Lee KH, Lee SR, Chae JK, Kim WH, Ko
JK, Nam GB, Choi KJ, Kim YH. Simple method of counterclock-
wise isthmus conduction block by comparing double potentials
and ﬂutter cycle length. Korean Circ J 2009;39:525—31.
12] Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E,
Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS,
Solomon SD, Spencer KT, Sutton MS, Stewart WJ, Chamber
Quantiﬁcation Writing Group, et al. Recommendations for
chamber quantiﬁcation: a report from the American Society of








[Left atrial volume index as a predictor for occurrence of atr
the Chamber Quantiﬁcation Writing Group, developed in con-
junction with the European Association of Echocardiography,
a branch of the European Society of Cardiology. J Am Soc
Echocardiogr 2005;18:1440—63.
[13] Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW,
Radford MJ. Validation of clinical classiﬁcation schemes for
predicting stroke: results from the National Registry of Atrial
Fibrillation. JAMA 2001;285:2864—70.
[14] Ohmura K, Kobayashi Y, Miyauchi Y, Endoh Y, Atarashi H,
Katoh T, Takano T. Electrocardiographic and electrophysiolog-
ical characteristics of atrial ﬁbrillation organized into atrial
ﬂutter by oral administration of class I antiarrhythmic agents.
Pacing Clin Electrophysiol 2003;26:692—702.
[15] Roithinger FX, Karch MR, Steiner PR, SippensGroenewegen
A, Lesh MD. Relationship between atrial ﬁbrillation and typ-
ical atrial ﬂutter in humans: activation sequence changes
during spontaneous conversion. Circulation 1997;96:3484—
91.
[16] Shin SH, Kim YH, Lee HS, Hwang GS, Kim BS, Rhee H, Kim JW,
Lim DS, Seo HS, Lee MH, Lee MH, Shim WJ, Oh DJ, Ro YM. Elec-
trophysiologic characteristics in the process of conversion from
atrial ﬁbrillation to atrial ﬂutter. Korean Circ J 2000;30:72—
81.
[17] Anne W, Willems R, Van der Merwe N, Van de Werf F, Ector H,
Heidbüchel H. Atrial ﬁbrillation after radiofrequency ablation
of atrial ﬂutter: preventive effect of angiotensin converting
enzyme inhibitors, angiotensin II receptor blockers, and diuret-
ics. Heart 2004;90:1025—30.
[18] Bertaglia E, Zoppo F, Bonso A, Proclemer A, Verlato R, Corò L,
Mantovan R, D’Este D, Zerbo F, Pascotto P, Northeastern Ital-
ian Study on Atrial Flutter Ablation Investigators. Long-term
follow-up of radiofrequency catheter ablation of atrial ﬂutter:
clinical course and predictors of atrial ﬁbrillation occurrence.
Heart 2004;90:59—63.
[19] Calkins H, Canby R, Weiss R, Taylor G, Wells P, Chinitz L, Milstein
S, Compton S, Oleson K, Sherfesee L, Onufer J, 100W Atakr II
[brillation after ablation of typical atrial ﬂutter 353
Investigator Group. Results of catheter ablation of typical atrial
ﬂutter. Am J Cardiol 2004;94:437—42.
20] Da Costa A, Romeyer C, Mourot S, Messier M, Cerisier A, Faure
E, Isaaz K. Factors associated with early atrial ﬁbrillation after
ablation of common atrial ﬂutter. A single-centre prospective
study. Eur Heart J 2002;23:498—506.
21] Gilligan DM, Zakaib JS, Fuller I, Shepard RK, Dan D, Wood MA,
Clemo HF, Stambler BS, Ellenbogen KA. Long-term outcome of
patients after successful radiofrequency ablation for typical
atrial ﬂutter. Pacing Clin Electrophysiol 2003;26:53—8.
22] Nabar A, Rodriguez LM, Timmermans C, van den Dool A, Smeets
JL, Wellens HJ. Effect of right atrial isthmus ablation on the
occurrence of atrial ﬁbrillation: observations in four patient
groups having type I atrial ﬂutter with or without associated
atrial ﬁbrillation. Circulation 1999;99:1441—5.
23] Paydak H, Kall JG, Burke MC, Rubenstein D, Kopp DE, Verdino
RJ, Wilber DJ. Atrial ﬁbrillation after radiofrequency ablation
of type I atrial ﬂutter: time to onset, determinants, and clinical
course. Circulation 1998;98:315—22.
24] Philippon F, Plumb VJ, Epstein AE, Kay GN. The risk of atrial
ﬁbrillation following radiofrequency catheter ablation of atrial
ﬂutter. Circulation 1995;92:430—5.
25] Ellis K, Wazni O, Marrouche N, Martin D, Gillinov M, McCarthy
P, Saad EB, Bhargava M, Schweikert R, Saliba W, Bash D,
Rossillo A, Erciyes D, Tchou P, Natale A. Incidence of atrial ﬁb-
rillation post-cavotricuspid isthmus ablation in patients with
typical atrial ﬂutter: left-atrial size as an independent predic-
tor of atrial ﬁbrillation recurrence. J Cardiovasc Electrophysiol
2007;18:799—802.
26] Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green
M, Kus T, Lambert J, Dubuc M, Gagné P, Nattel S, Thibault B.
Amiodarone to prevent recurrence of atrial ﬁbrillation. N Engl
J Med 2000;342:913—20.
27] AFFIRM Investigators. A comparison of rate control and
rhythm control in patients with atrial ﬁbrillation. NEJM
2002;347:1825—33.
